Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Cholera | Research article

“It depends how one understands it:” a qualitative study on differential uptake of oral cholera vaccine in three compounds in Lusaka, Zambia

Authors: Leonard W. Heyerdahl, Miguel Pugliese-Garcia, Sharon Nkwemu, Taniya Tembo, Chanda Mwamba, Rachel Demolis, Roma Chilengi, Bradford D. Gessner, Elise Guillermet, Anjali Sharma

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

The Zambian Ministry of Health implemented a reactive one-dose Oral Cholera Vaccine (OCV) campaign in April 2016 in three Lusaka compounds, followed by a pre-emptive second-round in December. Understanding uptake of this first-ever two-dose OCV campaign is critical to design effective OCV campaigns and for delivery of oral vaccines in the country and the region.

Methods

We conducted 12 Focus Group Discussions (FGDs) with men and women who self-reported taking no OCV doses and six with those self-reporting taking both doses. Simple descriptive analysis was conducted on socio-demographic and cholera-related data collected using a short questionnaire. We analyzed transcribed FGDs using the framework of dose, gender and geographic location.

Results

No differences were found by gender and location. All participants thought cholera to be severe and the reactive OCV campaign as relevant if efficacious. Most reported not receiving information on OCV side-effects and duration of protection. Those who took both doses listed more risk factors (including ‘wind’) and felt personally susceptible to cholera and protected by OCV. Some described OCV side-effects, mostly diarrhoea, vomiting and dizziness, as the expulsion of causative agents. Those who did not take OCV felt protected by their good personal hygiene practices or, thought of themselves and OCV as powerless against the multiple causes of cholera including poor living conditions, water, wind, and curse. Most of those who did not take OCV feared side-effects reported by others. Some interpreted side-effects as ‘western’ malevolence. Though > 80% discussants reported not knowing duration of protection, some who did not vaccinate, suggested that rather than rely on OCV which could lose potency, collective action should be taken to change the physical and economic environment to prevent cholera.

Conclusions

Due to incomplete information, individual decision-making was complex, rooted in theories of disease causation, perceived susceptibility, circulating narratives, colonial past, and observable outcomes of vaccination. To increase coverage, future OCV campaigns may benefit from better communication on eligibility and susceptibility, expected side effects, mechanism of action, and duration of protection. Governmental improvements in the physical and economic environment may increase confidence in OCV and other public health interventions among residents in Lusaka compounds.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mutreja A, Kim DW, Thomson NR, et al. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 2011;477:462–5.CrossRef Mutreja A, Kim DW, Thomson NR, et al. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 2011;477:462–5.CrossRef
2.
go back to reference WHO. First stepsfor managing an outbreak of acute diarrhoea. 2003. WHO. First stepsfor managing an outbreak of acute diarrhoea. 2003.
3.
go back to reference Gil AI, Louis VR, Rivera ING, et al. Occurrence and distribution of Vibrio cholerae in the coastal environment of Peru. Environ Microbiol. 2004;6:699–706.CrossRef Gil AI, Louis VR, Rivera ING, et al. Occurrence and distribution of Vibrio cholerae in the coastal environment of Peru. Environ Microbiol. 2004;6:699–706.CrossRef
4.
go back to reference Huq A, Sack RB, Nizam A, et al. Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh Critical Factors Influencing the Occurrence of Vibrio cholerae in the Environment of Bangladesh. Appl Environ Microbiol. 2005;71:4645.CrossRef Huq A, Sack RB, Nizam A, et al. Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh Critical Factors Influencing the Occurrence of Vibrio cholerae in the Environment of Bangladesh. Appl Environ Microbiol. 2005;71:4645.CrossRef
5.
go back to reference WHO Strategic Advisory Group of Experts on immunization (SAGE). Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 - conclusions and recommendations. Relev Epidemiol Hebd. 2009;84:517–32. WHO Strategic Advisory Group of Experts on immunization (SAGE). Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 - conclusions and recommendations. Relev Epidemiol Hebd. 2009;84:517–32.
9.
go back to reference Matapo B, Chizema E, Hangombe BM, et al. Successful multi-partner response to a cholera outbreak in Lusaka , Zambia 2016 : a case control study, vol. 43; 2016. p. 116–22. Matapo B, Chizema E, Hangombe BM, et al. Successful multi-partner response to a cholera outbreak in Lusaka , Zambia 2016 : a case control study, vol. 43; 2016. p. 116–22.
12.
go back to reference Kim DR, Jang MS, Teshome S, et al. A randomized, placebo-controlled trial evaluating safety and immunogenicity of the killed, bivalent, whole-cell Oral cholera vaccine in Ethiopia. Am J Trop Med Hyg. 2015;93:527–33.CrossRef Kim DR, Jang MS, Teshome S, et al. A randomized, placebo-controlled trial evaluating safety and immunogenicity of the killed, bivalent, whole-cell Oral cholera vaccine in Ethiopia. Am J Trop Med Hyg. 2015;93:527–33.CrossRef
13.
go back to reference Qadri F, Ali M, Chowdhury F, et al. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial. Lancet. 2015;386:1362–71.CrossRef Qadri F, Ali M, Chowdhury F, et al. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial. Lancet. 2015;386:1362–71.CrossRef
15.
go back to reference Azman AS, Luquero FJ, Ciglenecki I, et al. The impact of a one-dose versus two-dose Oral cholera vaccine regimen in outbreak settings: a modeling study. PLoS Med. 2015;12:1–18.CrossRef Azman AS, Luquero FJ, Ciglenecki I, et al. The impact of a one-dose versus two-dose Oral cholera vaccine regimen in outbreak settings: a modeling study. PLoS Med. 2015;12:1–18.CrossRef
16.
go back to reference Schaetti C, Hutubessy R, Ali SM, et al. Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance. BMC Public Health. 2009;9:99.CrossRef Schaetti C, Hutubessy R, Ali SM, et al. Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance. BMC Public Health. 2009;9:99.CrossRef
17.
go back to reference Schaetti C, Ali SM, Hutubessy R, et al. Social and cultural determinants of oral cholera vaccine uptake in Zanzibar. Hum Vaccin Immunother. 2012;8:1223–9.CrossRef Schaetti C, Ali SM, Hutubessy R, et al. Social and cultural determinants of oral cholera vaccine uptake in Zanzibar. Hum Vaccin Immunother. 2012;8:1223–9.CrossRef
18.
go back to reference Merten S, Schaetti C, Manianga C, et al. Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo. BMC Public Health. 2013;13:60.CrossRef Merten S, Schaetti C, Manianga C, et al. Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo. BMC Public Health. 2013;13:60.CrossRef
19.
go back to reference Sundaram N, Schaetti C, Chaignat C-L, et al. Socio-cultural determinants of anticipated acceptance of an oral cholera vaccine in Western Kenya. Epidemiol Infect. 2013;141:639–50.CrossRef Sundaram N, Schaetti C, Chaignat C-L, et al. Socio-cultural determinants of anticipated acceptance of an oral cholera vaccine in Western Kenya. Epidemiol Infect. 2013;141:639–50.CrossRef
21.
go back to reference Heyerdahl LW, Bagrey N, Demolis R, et al. Innovative Vaccine Delivery Strategies in Response to a Cholera Outbreak in the Challenging Context of Lake Chilwa. A rapid qualitative assessment. Vaccine. 2018;36(44):6491–6.CrossRef Heyerdahl LW, Bagrey N, Demolis R, et al. Innovative Vaccine Delivery Strategies in Response to a Cholera Outbreak in the Challenging Context of Lake Chilwa. A rapid qualitative assessment. Vaccine. 2018;36(44):6491–6.CrossRef
22.
go back to reference Demolis R, Botão C, Heyerdahl LW, et al. A Rapid Qualitative Assessment of Oral Cholera Vaccine Anticipated Acceptability in a Context of Resistance Towards Cholera Intervention in Nampula, Mozambique. Vaccine. 2018;36(44):6497–505.CrossRef Demolis R, Botão C, Heyerdahl LW, et al. A Rapid Qualitative Assessment of Oral Cholera Vaccine Anticipated Acceptability in a Context of Resistance Towards Cholera Intervention in Nampula, Mozambique. Vaccine. 2018;36(44):6497–505.CrossRef
23.
go back to reference Michael CA, Ogbuanu IU, Storms AD, et al. An assessment of the reasons for Oral poliovirus vaccine refusals in northern Nigeria. J Infect Dis. 2014;210:S125–30.CrossRef Michael CA, Ogbuanu IU, Storms AD, et al. An assessment of the reasons for Oral poliovirus vaccine refusals in northern Nigeria. J Infect Dis. 2014;210:S125–30.CrossRef
24.
go back to reference Murakami H, Kobayashi M, Hachiya M, et al. Refusal of oral polio vaccine in northwestern Pakistan: a qualitative and quantitative study. Vaccine. 2014;32:1382–7.CrossRef Murakami H, Kobayashi M, Hachiya M, et al. Refusal of oral polio vaccine in northwestern Pakistan: a qualitative and quantitative study. Vaccine. 2014;32:1382–7.CrossRef
25.
go back to reference Khan TM, Sahibzada MUK. Challenges to health workers and their opinions about parents’ refusal of oral polio vaccination in the Khyber Pakhtoon Khawa (KPK) province, Pakistan. Vaccine. 2016;34:2074–81.CrossRef Khan TM, Sahibzada MUK. Challenges to health workers and their opinions about parents’ refusal of oral polio vaccination in the Khyber Pakhtoon Khawa (KPK) province, Pakistan. Vaccine. 2016;34:2074–81.CrossRef
26.
go back to reference Closser S, Rosenthal A, Maes K, et al. The global context of vaccine refusal: insights from a systematic comparative ethnography of the global polio eradication initiative. Med Anthropol Q. 2016;30:321–41.CrossRef Closser S, Rosenthal A, Maes K, et al. The global context of vaccine refusal: insights from a systematic comparative ethnography of the global polio eradication initiative. Med Anthropol Q. 2016;30:321–41.CrossRef
27.
go back to reference Guest G, Namey E, McKenna K. How many focus groups are enough? Building an evidence base for nonprobability sample sizes. Field methods. 2017;29:3–22.CrossRef Guest G, Namey E, McKenna K. How many focus groups are enough? Building an evidence base for nonprobability sample sizes. Field methods. 2017;29:3–22.CrossRef
30.
go back to reference Wagner AL, Boulton ML, Sun X, et al. Perceptions of measles, pneumonia, and meningitis vaccines among caregivers in Shanghai, China, and the health belief model: a cross-sectional study. BMC Pediatr. 2017;17:143.CrossRef Wagner AL, Boulton ML, Sun X, et al. Perceptions of measles, pneumonia, and meningitis vaccines among caregivers in Shanghai, China, and the health belief model: a cross-sectional study. BMC Pediatr. 2017;17:143.CrossRef
31.
go back to reference Mosler H. A systematic approach to behavior change interventions for the water and sanitation sector in developing countries: a conceptual model, a review, and a guideline. Int J Environ Health Res. 2012;22:431–49.CrossRef Mosler H. A systematic approach to behavior change interventions for the water and sanitation sector in developing countries: a conceptual model, a review, and a guideline. Int J Environ Health Res. 2012;22:431–49.CrossRef
32.
go back to reference Nichter M. Vaccinations in the third world: a consideration of community demand. Soc Sci Med. 1995;41:617–32.CrossRef Nichter M. Vaccinations in the third world: a consideration of community demand. Soc Sci Med. 1995;41:617–32.CrossRef
33.
go back to reference Babaniyi O, Siziya S, Mukonka V, et al. Child nutrition and health campaign in 2012 in Zambia : coverage rates for measles , Oral polio vaccine , vitamin a , and De-worming. Open Vaccine J. 2013;6:1–8.CrossRef Babaniyi O, Siziya S, Mukonka V, et al. Child nutrition and health campaign in 2012 in Zambia : coverage rates for measles , Oral polio vaccine , vitamin a , and De-worming. Open Vaccine J. 2013;6:1–8.CrossRef
34.
go back to reference Central Statistical Office of Zambia. Central Statistical Office of Zambia, Ministry of Health of Zambia, ICF International. Zambia Demographic and Health Survey 2013–14. Rockville: Central Statistical Office/Zambia, Ministry of Health/Zambia, and ICF International; 2015. Central Statistical Office of Zambia. Central Statistical Office of Zambia, Ministry of Health of Zambia, ICF International. Zambia Demographic and Health Survey 2013–14. Rockville: Central Statistical Office/Zambia, Ministry of Health/Zambia, and ICF International; 2015.
35.
go back to reference Sundaram N, Schaetti C, Merten S, et al. Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach. BMC Public Health. 2016;16:36.CrossRef Sundaram N, Schaetti C, Merten S, et al. Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach. BMC Public Health. 2016;16:36.CrossRef
36.
go back to reference Kumar D, Chandra R, Mathur M, et al. Vaccine hesitancy: understanding better to address better. Isr J Health Policy Res. 2016;5:2.CrossRef Kumar D, Chandra R, Mathur M, et al. Vaccine hesitancy: understanding better to address better. Isr J Health Policy Res. 2016;5:2.CrossRef
37.
go back to reference Dillon-Malone C. Mutumwa nchimi healers and wizardry beliefs in Zambia. Soc Sci Med. 1988;26:1159–72.CrossRef Dillon-Malone C. Mutumwa nchimi healers and wizardry beliefs in Zambia. Soc Sci Med. 1988;26:1159–72.CrossRef
38.
go back to reference Bonnet D, Yaffré Y. Les maladies de passage : Transmissions, préventions et hygiènes en Afrique de l’Ouest. KARTHALA Editions; 2003. Bonnet D, Yaffré Y. Les maladies de passage : Transmissions, préventions et hygiènes en Afrique de l’Ouest. KARTHALA Editions; 2003.
39.
go back to reference Diallo Y. Conceptions populaires soso de la transmission des maladies et pratiques de prévention en Guinée maritime; 2003. Diallo Y. Conceptions populaires soso de la transmission des maladies et pratiques de prévention en Guinée maritime; 2003.
40.
go back to reference Epelboin A, Epelboin S. Ethnobotanique médicinale des Fulbé Bandé et des Nyokholonké; 1983. Epelboin A, Epelboin S. Ethnobotanique médicinale des Fulbé Bandé et des Nyokholonké; 1983.
42.
go back to reference Peretti-Watel P, Larson HJ, Ward JK, et al. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr. 2015;7:1–11. Peretti-Watel P, Larson HJ, Ward JK, et al. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr. 2015;7:1–11.
44.
go back to reference Venturas C, Umeh K. Health professional feedback on HPV vaccination roll-out in a developing country. Vaccine. 2017;35:1886–91.CrossRef Venturas C, Umeh K. Health professional feedback on HPV vaccination roll-out in a developing country. Vaccine. 2017;35:1886–91.CrossRef
45.
go back to reference Sugishita K, Africa S. Traditional medicine , Biomedicine and Christianity in modern Zambia Traditional Medicine , Biomedicine and Christianity in modern Zambia Kaori Sugishita, vol. 79; 2009. p. 435–54. Sugishita K, Africa S. Traditional medicine , Biomedicine and Christianity in modern Zambia Traditional Medicine , Biomedicine and Christianity in modern Zambia Kaori Sugishita, vol. 79; 2009. p. 435–54.
46.
go back to reference Green EC. Indigenous theories of contagious disease. Lanham: Rowman Altamira; 1999. Green EC. Indigenous theories of contagious disease. Lanham: Rowman Altamira; 1999.
47.
go back to reference Chillio L. Médicaments et prévention en milieu populaire songhay-zarma (Niger). Etudes Trav n. 2002;7:35. Chillio L. Médicaments et prévention en milieu populaire songhay-zarma (Niger). Etudes Trav n. 2002;7:35.
48.
go back to reference Jaffré Y, de Sardan JP. La construction sociale des maladies: les entités nosologiques populaires en Afrique de l'Ouest. FeniXX; 1999. Jaffré Y, de Sardan JP. La construction sociale des maladies: les entités nosologiques populaires en Afrique de l'Ouest. FeniXX; 1999.
49.
go back to reference Derrida J. Dissemination: Plato’s Pharmacy. trans. Barbara Johnson, The Norton Anthology of Theory and Criticism, eds. Vincent B. Leitch, William E. Cain, Laurie A. Fink, Barbara E. Johnson, John McGowan, and Jeffery J. Williams. New York: WW Norton; 2001. Derrida J. Dissemination: Plato’s Pharmacy. trans. Barbara Johnson, The Norton Anthology of Theory and Criticism, eds. Vincent B. Leitch, William E. Cain, Laurie A. Fink, Barbara E. Johnson, John McGowan, and Jeffery J. Williams. New York: WW Norton; 2001.
51.
go back to reference Nath B, Singh JV, Awasthi S, Bhushan V, Singh SKKVC. Satisfaction with immunization services in urban slums of L district. IJP 2009;76(5):479–83. Client satisfaction with immunization services in urban slums of Lucknow district. Indian J Pediatr. 2009;76(5):479–83.CrossRef Nath B, Singh JV, Awasthi S, Bhushan V, Singh SKKVC. Satisfaction with immunization services in urban slums of L district. IJP 2009;76(5):479–83. Client satisfaction with immunization services in urban slums of Lucknow district. Indian J Pediatr. 2009;76(5):479–83.CrossRef
52.
go back to reference Crocker-Buque T, Mindra G, Duncan R, et al. Immunization, urbanization and slums – a systematic review of factors and interventions; 2017. p. 1–16. Crocker-Buque T, Mindra G, Duncan R, et al. Immunization, urbanization and slums – a systematic review of factors and interventions; 2017. p. 1–16.
53.
go back to reference Peretti-Watel P, Larson HJ, Ward JK, Schulz WS, Verger P. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS currents. 2015;7. Peretti-Watel P, Larson HJ, Ward JK, Schulz WS, Verger P. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS currents. 2015;7.
54.
go back to reference Rosenberg CE. The cholera years: the United States in 1832, 1849, and 1866. Chicago: University of Chicago Press; 2009. Rosenberg CE. The cholera years: the United States in 1832, 1849, and 1866. Chicago: University of Chicago Press; 2009.
55.
go back to reference Hickler B, Guirguis S, Obregon R. Vaccine Special Issue on Vaccine Hesitancy. Vaccine. 2015;33:4155–6.CrossRef Hickler B, Guirguis S, Obregon R. Vaccine Special Issue on Vaccine Hesitancy. Vaccine. 2015;33:4155–6.CrossRef
Metadata
Title
“It depends how one understands it:” a qualitative study on differential uptake of oral cholera vaccine in three compounds in Lusaka, Zambia
Authors
Leonard W. Heyerdahl
Miguel Pugliese-Garcia
Sharon Nkwemu
Taniya Tembo
Chanda Mwamba
Rachel Demolis
Roma Chilengi
Bradford D. Gessner
Elise Guillermet
Anjali Sharma
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Cholera
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4072-6

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine